Viewing Study NCT00422903


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-25 @ 4:58 PM
Study NCT ID: NCT00422903
Status: COMPLETED
Last Update Posted: 2016-05-12
First Post: 2007-01-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
Sponsor: GlaxoSmithKline
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: EGF107692
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators